SCHEMBL57127

SCHEMBL57127

N=C(CCC(=O)OC(=O)O)OC(=O)O

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL6129571 0.93 ALDH1A1 (0.31) ALDH1A1
SCHEMBL3622179 0.84 ALDH1A1 (0.45) ALDH1A1TSHR
SCHEMBL7450423 0.83
Benzamide SCHEMBL1205193 0.79 L3MBTL1 (0.50) ALDH1A1TSHR
SCHEMBL43574 0.78 EGLN1 (0.43) ALDH1A1TSHR
SCHEMBL9277195 0.76 ALDH1A1 (0.32) ALDH1A1
SCHEMBL5888683 0.76 LMNA (0.53) ALDH1A1TSHR
SCHEMBL23042847 0.74
Bicarbonate SCHEMBL21084342 0.74 LMNA (0.50) ALDH1A1TSHR
SCHEMBL1580293 0.73 ALDH1A1 (0.33) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6174 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3689898-B1 LONG-ACTING CONJUGATE OF GLUCAGON-LIKE PEPTIDE-2 (GLP-2) DERIVATIVE HANMI PHARMACEUTICAL CO LTD (KR) 2026-04-29 EP claimed
EP-4717351-A1 A WHOLE-BLOOD COMPATIBLE DOUBLE-PEGYLATED MATRIX FOR EXTRACORPOREAL BLOOD TREATMENT Gambro Lundia AB (SE) 2026-04-01 EP claimed
EP-4717352-A1 A WHOLE-BLOOD COMPATIBLE MATRIX FOR EXTRACORPOREAL BLOOD TREATMENT Gambro Lundia AB (SE) 2026-04-01 EP claimed
US-20260049177-A1 PREPOLYMERS AND COMBINATIONS THEREWITH FOR WOUND REGENERATION Sunnybrook Research Institute (US) 2026-02-19 US claimed
EP-4687845-A1 PEGYLATED ORGANELLE COMPLEXES LUCA Science Inc. (JP) 2026-02-11 EP claimed
US-12540158-B2 Process for preparation of pegylated therapeutic proteins INDIAN INSTITUTE OF TECHNOLOGY DELHI (IN) 2026-02-03 US claimed
US-12508298-B2 Protein complex by use of a specific site of an immunoglobulin fragment for linkage HANMI PHARM. CO., LTD. (KR) 2025-12-30 US claimed
EP-4667566-A1 ARGININE DEIMINASE MUTANT, COVALENT DIMER AND CONJUGATE AND USE THEREOF Peg-Bio Biopharm Co., Ltd. (Chongqing) (CN) 2025-12-24 EP claimed
EP-4615512-A1 PREPOLYMERS AND COMBINATIONS THEREWITH FOR WOUND REGENERATION Sunnybrook Research Institute (CA) 2025-09-17 EP claimed
US-20250270275-A1 PHARMACEUTICAL COMPOSITION COMPRISING POLYPEPTIDE D&D PHARMATECH INC. (KR) 2025-08-28 US claimed
US-5738846-A CONJUGATING INTERFERON TO POLYMER STRAND HAVING ONE OR BOTH ENDS ACTIVATED BY CARBAMATE-OR AMIDE-FORMING GROUPS ENZON, INC. (US) 1998-04-14 US claimed
US-5711944-A Interferon polymer conjugates ENZON, INC. (US) 1998-01-27 US claimed
EP-0788515-A1 NON-ANTIGENIC BRANCHED POLYMER CONJUGATES ENZON, INC. (US) 1997-08-13 EP claimed
US-5643575-A Non-antigenic branched polymer conjugates ENZON, INC. (US) 1997-07-01 US claimed
WO-1997018832-A1 INTERFERON-POLYMER CONJUGATES AND PROCESS FOR PREPARING THE SAME ENZON, INC. (US) 1997-05-29 WO claimed
EP-0730470-A1 IMPROVED INTERFERON POLYMER CONJUGATES ENZON, INC. (US) 1996-09-11 EP claimed
US-5446134-A Reacting bis(fluorosulfonyl)methane salt with cyanogen halide or pseudohalide CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1995-08-29 US claimed
WO-1995013090-A1 IMPROVED INTERFERON POLYMER CONJUGATES ENZON, INC. (US) 1995-05-18 WO claimed
WO-1995011924-A1 NON-ANTIGENIC BRANCHED POLYMER CONJUGATES ENZON, INC. (US) 1995-05-04 WO claimed
WO-1994020453-A1 TAXOL POLYALKYLENE OXIDE CONJUGATES OF TAXOL AND TAXOL INTERMEDIATES ENZON, INC. (US) 1994-09-15 WO claimed